James Manuso S.J.'s most recent trade in Opus Genetics Inc. was a trade of 79,592 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Opus Genetics Inc. | James Manuso S.J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 79,592 | 79,592 | - | - | Stock Option (Right to Buy) | |
| Opus Genetics Inc. | Manuso S.J. James | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 79,504 | 261,763 | - | 0 | Common Stock | |
| TuHURA Biosciences Inc. | James S.J. Manuso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 59,590 | 59,590 | - | - | Options (Right to Buy) | |
| Opus Genetics Inc. | James S.J. Manuso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 50,222 | 182,259 | - | - | Common Stock | |
| TuHURA Biosciences Inc. | James S.J. Manuso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 13,553 | 13,553 | - | - | Options (Right to Buy) | |
| TuHURA Biosciences Inc. | James S.J. Manuso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 13,553 | 13,553 | - | - | Options (Right to Buy) | |
| Opus Genetics Inc. | James S.J. Manuso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 41,143 | 132,037 | - | 0 | Common Stock | |
| Opus Genetics Inc. | James S.J. Manuso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 35,181 | 35,181 | - | - | Stock Option (Right to Buy) | |
| Opus Genetics Inc. | James Manuso S.J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 22,090 | 90,894 | - | - | Common Stock | |
| Opus Genetics Inc. | James S.J. Manuso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 10,976 | 68,804 | - | 0 | Common Stock | |
| Opus Genetics Inc. | James S.J. Manuso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 9,639 | 9,639 | - | - | Stock Option | |
| Opus Genetics Inc. | James S.J. Manuso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 18,544 | 55,009 | - | - | Common Stock | |
| Opus Genetics Inc. | James S.J. Manuso | Director | 11 Oct 2022 | 787 | 0 | - | - | Series B Warrant (right to buy) | ||
| Opus Genetics Inc. | James S.J. Manuso | Director | 11 Oct 2022 | 787 | 36,465 | - | 0 | Common Stock | ||
| Opus Genetics Inc. | James S.J. Manuso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 14,108 | 35,678 | - | - | Common Stock | |
| Opus Genetics Inc. | James S.J. Manuso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Opus Genetics Inc. | James S.J. Manuso | Director | Purchase of securities on an exchange or from another person at price $ 1.99 per share. | 20 May 2022 | 5,000 | 21,570 | - | 2.0 | 9,950 | Common Stock |
| Opus Genetics Inc. | James S.J. Manuso | Director | Purchase of securities on an exchange or from another person at price $ 3.50 per share. | 18 Nov 2021 | 2,000 | 16,570 | - | 3.5 | 7,000 | Common Stock |
| Opus Genetics Inc. | James S.J. Manuso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Opus Genetics Inc. | James S.J. Manuso | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Nov 2020 | 6,697 | 6,697 | - | - | Series A Warrant (right to buy) | |
| Opus Genetics Inc. | James S.J. Manuso | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Nov 2020 | 4,434 | 14,570 | - | - | Common Stock | |
| Opus Genetics Inc. | James S.J. Manuso | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Nov 2020 | 787 | 787 | - | - | Series B Warrant (right to buy) | |
| Opus Genetics Inc. | James S.J. Manuso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2020 | 5,000 | 5,000 | - | - | Stock Option (right to buy) |